good entry point. glad you were able to buy in. i bought at 284 so with the exception of some nice dividend payments i am down a bit...
One of the advantages that VZ has is that it is shielded relative to most large caps by having a primarily domestic operation. Bell weather during tough market days.
I wasn't aware that President Carter was being treated with Keytruda, thats pretty interesting.
I think organic growth could be eclipsed by M&A activity this year. I think there are a few target companies relatively cheap and with cheap money still available it makes sense in the near term.
I hope you are right. I made a bit of an impulsive purchase here. Not sure how long I will keep my money tied up here.
The full story was a good read. I was very encouraged by what was said and how Dhillon answered.
OncoSec should gain some attention as well if you are looking for additional plays in the space.
Validates what many of us long ONCS already knew. The platform works and will transform oncology treatments for years to come.
That had nothing to do with a financing deal. Its common for a company with a growing number of employees to expand its available shares to retain its talent in the future.